Meeting
2024 ASCO Annual Meeting
Multilevel factors associated with delays to neoadjuvant chemotherapy among young adults with operable breast cancer.
Authors
Melissa Beauchemin
Columbia University School of Nursing, New York, NY
Melissa Beauchemin , Margaux Wooster , David DeStephano , Sarah Harkins , Shikun Wang , Jason Dennis Wright , Justine Kahn , Melissa Kate Accordino , Dawn L. Hershman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Quality Care/Health Services Research
Track
Care Delivery and Quality Care
Sub Track
Health Services Research
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 11091)
DOI
10.1200/JCO.2024.42.16_suppl.11091
Abstract #
11091
Poster Bd #
286
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Does race influence long-term outcomes after neoadjuvant chemotherapy in breast cancer: A National Cancer Database analysis.
First Author: Arya Mariam Roy
Poster
2016 ASCO Annual Meeting
Investigating denosumab as add-on neoadjuvant treatment for hormone receptor-negative, RANK-positive or RANK-negative primary breast cancer and two different nab-Paclitaxel schedules - 2x2 factorial design (GeparX).
First Author: Sherko Kümmel
Poster
2012 ASCO Annual Meeting
Magnetic resonance imaging (MRI) evaluation of pathologic complete response (pCR) in different breast cancer subtypes after neoadjuvant chemotherapy (NAC).
First Author: Lucia Gonzalez-Cortijo
Poster
2024 ASCO Annual Meeting
Impact of extent of disease at presentation on oncologic outcomes according to pathologic response to neoadjuvant systemic therapy among participants of the I-SPY2 clinical trial.
First Author: Roberto Antonio Leon-Ferre